W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
|
Back to Search Results |
|
Catalog Number RLT261414 |
Device Problem
No Apparent Adverse Event (3189)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 11/24/2017 |
Event Type
Injury
|
Manufacturer Narrative
|
(b)(4).Medical devices: patient medications include toprol and zafera.Ct images dated (b)(6) 2017 were received by gore from the facility and an imaging evaluation was performed.A type ia endoleak was verified from the proximal edge of the excluder® device.The anatomical angle of the infrarenal neck was measured at 59 degrees, which falls within recommendations of the gore® excluder® aaa endoprosthesis instructions for use (ifu).There was approximately 2 cm of length from the lowest renal artery to the proximal end of the endoprosthesis.No other endoleaks were observed.The inferior mesenteric artery was noted as patent and filling retrograde, but not filling the aneurysm sac.A review of the manufacturing records for the device verified that the lot met all pre-release specifications.Per ifu, adverse events that may occur and/or require intervention include but are not limited to endoleak.
|
|
Event Description
|
On (b)(6) 2014, the patient was implanted with three gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.On (b)(6) 2017, computed tomography (ct) scan reportedly revealed a proximal type i endoleak contributing to aneurysm enlargement (amount unknown).A lack of proximal device apposition to the vessel wall was also reported.On (b)(6) 2018, the patient underwent a re-intervention procedure whereby two excluder® aortic extender components were implanted proximally to treat the type i endoleak.The endoleak was resolved and the patient tolerated the procedure.
|
|
Manufacturer Narrative
|
Original date of implant was (b)(6) 2014.
|
|
Search Alerts/Recalls
|
|
|